CTOs on the Move

Greenway Medical Technologies, Inc.

www.greenwaymedical.com

 
Greenway Medical Technologies provides the latest in ambulatory healthcare business solutions and services to 20000 healthcare providers and professionals nationwide, in 30 specialties and subspecialties, by enhancing the delivery of patient care
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

e-MedRecords

e-MedRecords is a Sparta, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Agency for Workforce Innovation

Agency for Workforce Innovation is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BENAS Environmental Services

BENAS Environmental Services, Inc. is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JSA Healthcare Corp

JSA Healthcare Corporation is a leading provider of high quality healthcare services. Our facilities include 34 primary care practices in the greater Tampa Bay and Orlando areas under the JSA Medical Group name.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.